Universal cervical-length screening to prevent preterm birth: a cost-effectiveness analysis.

PubWeight™: 1.57‹?› | Rank: Top 4%

🔗 View Article (PMID 21157771)

Published in Ultrasound Obstet Gynecol on May 24, 2011

Authors

E F Werner1, C S Han, C M Pettker, C S Buhimschi, J A Copel, E F Funai, S F Thung

Author Affiliations

1: Department of Obstetrics, Gynecology & Reproductive Sciences, Section of Maternal Fetal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA. erika.werner@yale.edu

Associated clinical trials:

A Randomized Trial of Pessary in Singleton Pregnancies With a Short Cervix (TOPS) | NCT02901626

Articles citing this

Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol (2011) 2.95

Screening for gestational diabetes mellitus: are the criteria proposed by the international association of the Diabetes and Pregnancy Study Groups cost-effective? Diabetes Care (2012) 1.36

Risk factors for preterm birth in an international prospective cohort of nulliparous women. PLoS One (2012) 1.16

Progesterone supplementation and the prevention of preterm birth. Rev Obstet Gynecol (2011) 1.11

Universal cervical-length screening and vaginal progesterone prevents early preterm births, reduces neonatal morbidity and is cost saving: doing nothing is no longer an option. Ultrasound Obstet Gynecol (2011) 1.01

Progesterone to prevent spontaneous preterm birth. Semin Fetal Neonatal Med (2013) 1.00

A blueprint for the prevention of preterm birth: vaginal progesterone in women with a short cervix. J Perinat Med (2013) 0.95

Transabdominal evaluation of uterine cervical length during pregnancy fails to identify a substantial number of women with a short cervix. J Matern Fetal Neonatal Med (2012) 0.95

Strategies to prevent preterm birth. Front Immunol (2014) 0.91

Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study. Ultrasound Obstet Gynecol (2016) 0.87

Vaginal progesterone in risk reduction of preterm birth in women with short cervix in the midtrimester of pregnancy. Int J Womens Health (2012) 0.85

Vaginal progesterone to reduce the rate of preterm birth and neonatal morbidity: a solution at last. Womens Health (Lond Engl) (2011) 0.84

Activity restriction among women with a short cervix. Obstet Gynecol (2013) 0.83

Universal cervical length screening: implementation and outcomes. Am J Obstet Gynecol (2016) 0.80

Maternal Serum Screening Markers and Adverse Outcome: A New Perspective. J Clin Med (2014) 0.80

Precocious cervical ripening as a screening target to predict spontaneous preterm delivery among asymptomatic singleton pregnancies: a systematic review. Am J Obstet Gynecol (2014) 0.78

Is sonographic assessment of the cervix necessary and helpful? Clin Obstet Gynecol (2012) 0.76

Applying Precision Public Health to Prevent Preterm Birth. Front Public Health (2017) 0.75

Beyond Cervical Length: A Pilot Study of Ultrasonic Attenuation for Early Detection of Preterm Birth Risk. Ultrasound Med Biol (2015) 0.75

Impaired ultrasonographic cervical assessment after voiding: a randomized controlled trial. Obstet Gynecol (2013) 0.75

Actions of progestins for the inhibition of cervical ripening and uterine contractions to prevent preterm birth. Facts Views Vis Obgyn (2012) 0.75

Can Transabdominal Scan Predict a Short Cervix by Transvaginal Scan? Obstet Gynecol Int (2017) 0.75

Articles by these authors

Integration of cytogenetic landmarks into the draft sequence of the human genome. Nature (2001) 10.96

Genomics. Genome project standards in a new era of sequencing. Science (2009) 7.72

Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med (2000) 4.95

Perinatal outcome of fetal complete atrioventricular block: a multicenter experience. J Am Coll Cardiol (1991) 2.33

Anti-Ro/SSA antibodies and congenital heart block: necessary but not sufficient. Arthritis Rheum (2001) 2.23

Assessment of fetal renal reserve in low level obstructive uropathy. Lancet (1989) 2.06

Analysis of ten Brucella genomes reveals evidence for horizontal gene transfer despite a preferred intracellular lifestyle. J Bacteriol (2009) 1.76

The use of percutaneous umbilical blood sampling in immune thrombocytopenic purpura. Am J Obstet Gynecol (1988) 1.71

Diagnostic fetal umbilical blood sampling in the management of isoimmunization. Am J Obstet Gynecol (1988) 1.70

Fission yeast rad12+ regulates cell cycle checkpoint control and is homologous to the Bloom's syndrome disease gene. Mol Cell Biol (1998) 1.53

The top3(+) gene is essential in Schizosaccharomyces pombe and the lethality associated with its loss is caused by Rad12 helicase activity. Nucleic Acids Res (1999) 1.44

Fetal echocardiographic screening for congenital heart disease: the importance of the four-chamber view. Am J Obstet Gynecol (1987) 1.43

Nicked free beta-subunit of human chorionic gonadotropin: a potential new marker for Down syndrome screening. Am J Obstet Gynecol (1996) 1.40

Is the fetal brain-sparing effect a risk factor for the development of intraventricular hemorrhage in the preterm infant? Ultrasound Obstet Gynecol (1996) 1.39

Maternal serum uric acid levels in preeclamptic women with multiple gestations. Am J Perinatol (1997) 1.39

Normal nuchal thickness in the midtrimester indicates reduced risk of Down syndrome in pregnancies with abnormal triple-screen results. Am J Obstet Gynecol (1995) 1.39

Immunohistochemical localization of inducible nitric oxide synthase on human fetal amnion in intra-amniotic infection. Am J Obstet Gynecol (1998) 1.38

ISUOG Practice Guidelines (updated): sonographic screening examination of the fetal heart. Ultrasound Obstet Gynecol (2013) 1.35

Prenatal diagnosis of congenital heart disease affects preoperative acidosis in the newborn patient. J Thorac Cardiovasc Surg (2001) 1.31

Langerhans' cell histiocytosis of the spine. Analysis of twenty-three cases. Spine (Phila Pa 1976) (1999) 1.17

Management outcome and follow-up of fetal tachycardia. J Am Coll Cardiol (1994) 1.14

Plasma levels of thrombin-antithrombin complexes predict preterm premature rupture of the fetal membranes. J Matern Fetal Med (2001) 1.13

Outcome of prenatally detected cardiac malformations. Am J Cardiol (1992) 1.12

Prenatal screening for Down's syndrome--a search for the family's values. N Engl J Med (1999) 1.11

In utero exchange transfusion by direct intravascular injection in severe erythroblastosis fetalis. N Engl J Med (1986) 1.10

In utero diagnosis and treatment of fetal supraventricular tachycardia. Semin Perinatol (1985) 1.08

Treatment of fetal supraventricular tachyarrhythmias. J Clin Ultrasound (1985) 1.08

Tricuspid valve disease with significant tricuspid insufficiency in the fetus: diagnosis and outcome. J Am Coll Cardiol (1991) 1.08

Giant cell tumor of the scapula associated with secondary aneurysmal bone cyst. J Korean Med Sci (1991) 1.04

Systematic review of sonographic findings of placental mesenchymal dysplasia and subsequent pregnancy outcome. Ultrasound Obstet Gynecol (2013) 1.02

Value of culdocentesis in the diagnosis of ectopic pregnancy. Obstet Gynecol (1985) 1.01

Trophoblast interferons. Placenta (1999) 1.01

Fetal atrioventricular valve insufficiency associated with nonimmune hydrops: a two-dimensional echocardiographic and pulsed Doppler ultrasound study. Circulation (1985) 1.00

Residency selection: should interviewers be given applicants' board scores? Am J Obstet Gynecol (2001) 1.00

Production of medium-chain-length polyhydroxyalkanoates by high-cell-density cultivation of Pseudomonas putida under phosphorus limitation. Biotechnol Bioeng (2000) 1.00

Primary alveolar soft part sarcoma of bone. Histopathology (1999) 1.00

Progestin and thrombin regulate tissue factor expression in human term decidual cells. J Clin Endocrinol Metab (2009) 0.98

Diagnosis of ectopic pregnancy: value of the discriminatory human chorionic gonadotropin zone. Obstet Gynecol (1985) 0.97

The safety of intraoperative autologous blood collection and autotransfusion during cesarean section. Am J Obstet Gynecol (1998) 0.96

Diagnosis of fetal anemia with Doppler ultrasound in the pregnancy complicated by maternal blood group immunization. Ultrasound Obstet Gynecol (1995) 0.96

Sonographic monitoring to guide the performance of postabortal uterine curettage. Am J Obstet Gynecol (1985) 0.95

Intrauterine fetal demise and hemostatic failure: the fetal death syndrome. Clin Obstet Gynecol (1985) 0.94

First-trimester growth restriction and fetal aneuploidy: the effect of type of aneuploidy and gestational age. Am J Obstet Gynecol (1997) 0.93

Hypoplastic left heart syndrome: prenatal diagnosis, clinical profile, and management. Am J Obstet Gynecol (1991) 0.93

Single umbilical artery: does it matter which artery is missing? Am J Obstet Gynecol (1995) 0.92

Reduction-oxidation (redox) state regulation of matrix metalloproteinase activity in human fetal membranes. Am J Obstet Gynecol (2000) 0.92

Color Doppler imaging of placental masses: differential diagnosis and fetal outcome. Ultrasound Obstet Gynecol (2000) 0.92

Hyperechoic fetal bowel: the perinatal consequences. Prenat Diagn (1994) 0.91

Neocolpopoiesis with split-thickness skin graft as a surgical treatment of vaginal agenesis: retrospective review of 201 cases. Am J Obstet Gynecol (1996) 0.90

Foramen ovale size in the normal and abnormal human fetal heart: an indicator of transatrial flow physiology. Ultrasound Obstet Gynecol (1991) 0.90

Effects of emitted Qi on in vitro natural killer cell cytotoxic activity. Am J Chin Med (2001) 0.90

Cytotoxicity and sister chromatid exchanges induced in vitro by six anticancer drugs developed in the People's Republic of China. J Natl Cancer Inst (1983) 0.88

Lithium and rubidium interactions with sodium- and potassium-dependent adenosine triphosphatase: a molecular basis for the pharmacological actions of these ions. Mol Pharmacol (1974) 0.87

Prevention of Rh isoimmunization and treatment of the compromised fetus. Semin Perinatol (1988) 0.87

Proteomics of the amniotic fluid in assessment of the placenta. Relevance for preterm birth. Placenta (2008) 0.87

Prenatal sonographic findings in 187 fetuses with Down syndrome. Prenat Diagn (1997) 0.86

Pregnancy-related thrombosis in a woman with congenital afibrinogenemia: a report of two successful pregnancies. Am J Hematol (2004) 0.86

Isolated major congenital heart disease. Ultrasound Obstet Gynecol (2001) 0.86

Elevated amniotic fluid levels of leukemia inhibitory factor, interleukin 6, and interleukin 8 in intra-amniotic infection. Am J Obstet Gynecol (1998) 0.86

The role of central 5-hydroxytryptamine in acupuncture analgesia. Sci Sin (1979) 0.85

Fetal platelet counts correlate with the severity of the anemia in red-cell alloimmunization. Obstet Gynecol (1993) 0.85

A study of the effect of energy healing on in vitro tumor cell proliferation. J Altern Complement Med (1999) 0.85

First-trimester prenatal diagnosis of osteogenesis imperfecta type II by DNA analysis and sonography. Prenat Diagn (1993) 0.84

Electrophysiological principles and fetal antiarrhythmic therapy. Ultrasound Obstet Gynecol (1991) 0.84

Placental growth factor in the cerebrospinal fluid of women with preeclampsia. Int J Gynaecol Obstet (2005) 0.84

Activation of NF-kappaB mediates the PMA-induced differentiation of K562 cells. Cancer Lett (1998) 0.83

Strategies for reducing the frequency of preeclampsia in pregnancies with insulin-dependent diabetes mellitus. Am J Perinatol (1996) 0.83

Prenatal prediction of neonatal outcome in the extremely low-birth-weight infant. Am J Obstet Gynecol (1998) 0.83

Dual roles of amniotic fluid nitric oxide and prostaglandin E2 in preterm labor with intra-amniotic infection. Am J Perinatol (1998) 0.83

Changes in fetal hemodynamics with ritodrine tocolysis. Ultrasound Obstet Gynecol (2001) 0.83

Management of the Rh-sensitized mother. Clin Perinatol (1995) 0.83

The role of amniotic fluid L-selectin, GRO-alpha, and interleukin-8 in the pathogenesis of intraamniotic infection. Am J Obstet Gynecol (1998) 0.83

Change in cervical length after cerclage as a predictor of preterm delivery. Obstet Gynecol (2000) 0.82

Can risk factor assessment replace universal screening for gonorrhea and Chlamydia in the third trimester? Am J Perinatol (2001) 0.82

Brain-derived neurotrophic factor gene polymorphisms and mirtazapine responses in Koreans with major depression. J Psychopharmacol (2009) 0.82

Erythropoietin in human fetuses with immune hemolytic anemia and hydrops fetalis. Obstet Gynecol (1993) 0.82

Congenital heart disease and extracardiac anomalies: associations and indications for fetal echocardiography. Am J Obstet Gynecol (1986) 0.82

Proteomic technology and delayed interval delivery in multiple pregnancies. Int J Gynaecol Obstet (2005) 0.82

Color Doppler flow patterns and flow velocity waveforms of the intraplacental fetal circulation in growth-retarded fetuses. Am J Obstet Gynecol (1994) 0.82

Fetal transcerebellar diameter in Down syndrome. Obstet Gynecol (1997) 0.82

Intestinal parasites and other infections during pregnancy in Southeast Asian refugees. J Reprod Med (1985) 0.81

Glycosylated hemoglobin in insulin-dependent diabetes mellitus related to preeclampsia. Am J Perinatol (1998) 0.81

Multifocal, metachronous giant-cell tumor of the ulna. A case report. J Bone Joint Surg Am (1999) 0.81

The impact of fetal echocardiography on perinatal outcome. Ultrasound Med Biol (1986) 0.81

Human labor is associated with reduced decidual cell expression of progesterone, but not glucocorticoid, receptors. J Clin Endocrinol Metab (2010) 0.81

Direct fetal therapy for cardiac arrhythmias: who, what, when, where, why and how? Ultrasound Obstet Gynecol (1991) 0.81

Growth of the fetal gall bladder in normal pregnancies. Ultrasound Obstet Gynecol (1994) 0.81

Indications for fetal echocardiography. Pediatr Cardiol (2004) 0.81

Hermansky-Pudlak syndrome in pregnancy: two case studies. Am J Obstet Gynecol (1985) 0.81

Malignant myoepithelioma of the humerus with a satellite lesion: a case report and literature review. Br J Radiol (2010) 0.80

Cardiac growth in fetuses of diabetic mothers with good metabolic control. J Pediatr (1991) 0.80

Fetuses with Down syndrome have disproportionately shortened frontal lobe dimensions on ultrasonographic examination. Am J Obstet Gynecol (1992) 0.80

The effect of different human chorionic gonadotropin assay sensitivity on screening for ectopic pregnancy. Am J Obstet Gynecol (1985) 0.80

Fetal echocardiography and fetal cardiology: indications, diagnosis and management. Semin Perinatol (1993) 0.80

Human caudal appendage diagnosed prenatally with ultrasound. Obstet Gynecol (2000) 0.80

Blood flow velocity waveforms of the abdominal arteries in appropriate- and small-for-gestational-age fetuses. Ultrasound Obstet Gynecol (1995) 0.79

The role of urinary soluble endoglin in the diagnosis of pre-eclampsia: comparison with soluble fms-like tyrosine kinase 1 to placental growth factor ratio. BJOG (2009) 0.79

Congenital heart defects in twin gestations. Minerva Ginecol (2009) 0.79

VEGF, bFGF and their receptors at the fetal-maternal interface of the rhesus monkey. Placenta (2004) 0.78